• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

MELD-good for many, not as good for others … at least for now.

作者信息

Schiano Thomas

机构信息

Mount Sinai School of Medicine, New York, NY, USA.

出版信息

Hepatol Int. 2013 Jun;7(2):306-8. doi: 10.1007/s12072-012-9393-0. Epub 2012 Jul 25.

DOI:10.1007/s12072-012-9393-0
PMID:26201766
Abstract
摘要

相似文献

1
MELD-good for many, not as good for others … at least for now.终末期肝病模型评分对许多人有益，但对其他人则不然……至少目前如此。
Hepatol Int. 2013 Jun;7(2):306-8. doi: 10.1007/s12072-012-9393-0. Epub 2012 Jul 25.
2
Value of the MELD score for the assessment of pre- and post-liver transplantation survival.终末期肝病模型（MELD）评分在评估肝移植前后生存率方面的价值。
Transplant Proc. 2005 Jul-Aug;37(6):2863-4. doi: 10.1016/j.transproceed.2005.05.007.
3
Variability of MELD score during the year before liver transplantation.肝移植前一年中终末期肝病模型（MELD）评分的变异性。
Transplant Proc. 2005 Nov;37(9):3887-8. doi: 10.1016/j.transproceed.2005.09.164.
4
Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.预测肝硬化患者晚期食管静脉曲张再出血的终末期肝病模型（MELD）评分
Hepatogastroenterology. 2008 May-Jun;55(84):1055-8.
5
The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.丙氨酸氨基转移酶与天冬氨酸氨基转移酶比值及终末期肝病模型评分对病毒性肝硬化患者的1年和3个月预后评估价值
Am J Gastroenterol. 2002 Nov;97(11):2855-60. doi: 10.1111/j.1572-0241.2002.07053.x.
6
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?六种评分系统评估终末期肝硬化患者行原位肝移植的适应证：谁是赢家？
Liver Transpl. 2010 Aug;16(8):964-73. doi: 10.1002/lt.22093.
7
[The prognostic value of end-stage liver disease model in liver cirrhosis].[终末期肝病模型在肝硬化中的预后价值]
Zhonghua Nei Ke Za Zhi. 2005 Nov;44(11):822-4.
8
Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.比较肝静脉压力梯度和两种终末期肝病模型预测失代偿性肝硬化患者生存的价值。
J Clin Gastroenterol. 2012 Nov-Dec;46(10):880-6. doi: 10.1097/MCG.0b013e31825f2622.
9
MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure.终末期肝病模型（MELD）评分：在非对乙酰氨基酚所致急性肝衰竭中的效用及与国王学院标准的比较
J Coll Physicians Surg Pak. 2012 Aug;22(8):492-6.
10
Prognosis after liver transplantation predicted by preoperative MELD score.术前终末期肝病模型（MELD）评分预测肝移植后的预后。
Transplant Proc. 2006 Sep;38(7):2095-6. doi: 10.1016/j.transproceed.2006.06.031.

本文引用的文献

1
MELD Exceptions and Rates of Waiting List Outcomes.MELD 例外和候补名单结果的比例。
Am J Transplant. 2011 Nov;11(11):2362-71. doi: 10.1111/j.1600-6143.2011.03735.x. Epub 2011 Sep 15.
2
The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortality.等待肝移植期间终末期肝病模型评分变化对肝移植术后死亡率的影响。
Hepatol Int. 2012 Apr;6(2):491-7. doi: 10.1007/s12072-011-9287-6. Epub 2011 Jun 30.
3
The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
终末期肝病模型评分：肝硬化损伤患者死亡的独立预后因素。
Arch Surg. 2011 Sep;146(9):1074-8. doi: 10.1001/archsurg.2011.109. Epub 2011 May 16.
4
Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy.终末期肝病模型评分可预测妊娠期间肝硬化患者的结局。
Clin Gastroenterol Hepatol. 2011 Aug;9(8):694-9. doi: 10.1016/j.cgh.2011.03.036. Epub 2011 Apr 15.
5
The MELD score in patients awaiting liver transplant: strengths and weaknesses.等待肝移植患者的 MELD 评分：优势和劣势。
J Hepatol. 2011 Jun;54(6):1297-306. doi: 10.1016/j.jhep.2010.11.008. Epub 2010 Nov 20.
6
Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.肝硬化患者手术后的死亡率：Child-Turcotte-Pugh、MELD 和 MELDNa 评分的比较。
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):51-9. doi: 10.1097/MEG.0b013e3283407158.
7
Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?阿根廷肝移植基于终末期肝病模型的分配系统：它在美国以外的地方有效吗？
HPB (Oxford). 2010 Sep;12(7):456-64. doi: 10.1111/j.1477-2574.2010.00199.x.
8
Liver transplantation for cholangiocarcinoma.肝移植治疗胆管细胞癌。
Transpl Int. 2010 Jul;23(7):692-7. doi: 10.1111/j.1432-2277.2010.01108.x. Epub 2010 May 20.
9
Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.肝移植时增加终末期肝病模型评分会导致住院时间延长和整体重症监护病房费用增加。
Liver Transpl. 2010 May;16(5):668-77. doi: 10.1002/lt.22027.
10
Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.终末期肝病模型评分引入前后肝移植等待名单上的生存率
Transplant Proc. 2010 Mar;42(2):407-11. doi: 10.1016/j.transproceed.2010.01.005.